Sinopharm Technology Co., Ltd. (08156): Yu Bingming was elected as an independent non-executive director

Zhitong Finance App News, Sinopharm Technology Co., Ltd. (08156) issued an announcement. After the annual shareholders' meeting, Dr. Cheng Yanjie (Dr. Cheng) has taken turns to retire as a non-executive director of the Company.

Mr. Diao Zhiqiang (Mr. Diao) and Mr. Yu Bingming (Mr. Yu) have both been elected by the shareholders of the Company as independent non-executive directors of the Company at the Annual General Meeting of Shareholders.

The board of directors further announced that Mr. Xu Dongan (Mr. Xu) has resigned as an independent non-executive director of the Company due to other commercial matters, with effect from December 19, 2025 (after the end of the Annual General Meeting of Shareholders).

The Board of Directors further announced the following changes in the composition of the board committee, all of which took effect on December 19, 2025 (after the end of the Annual General Meeting of Shareholders): (1) Mr. Hui has resigned as Chairman of the Company's Nomination Committee and a member of the Audit Committee, Remuneration Committee and Nomination Committee; (2) Ms. Guo Shuyi has been appointed as a member of the Remuneration Committee and Nomination Committee; (3) Mr. Liu Fei has been appointed as a member of the Audit Committee, Remuneration Committee and Nomination Committee; and (5) Mr. Yu has been appointed as a member of the Audit Committee, Remuneration Committee and Nomination Committee; and (5) Mr. Yu has been appointed as a member of the Audit Committee, Remuneration Committee and Nomination Committee; and (5) Mr. Yu has been appointed as a member of the Audit Committee, Remuneration Committee and Nomination Committee; and (5) Mr. Yu has been appointed as a member of the Audit Committee and Remuneration Committee Member of the Committee and Nomination Committee.